ITMI20032054A1 - Processo per la preparazione di sospensioni farmaceutiche da inalare. - Google Patents

Processo per la preparazione di sospensioni farmaceutiche da inalare.

Info

Publication number
ITMI20032054A1
ITMI20032054A1 IT002054A ITMI20032054A ITMI20032054A1 IT MI20032054 A1 ITMI20032054 A1 IT MI20032054A1 IT 002054 A IT002054 A IT 002054A IT MI20032054 A ITMI20032054 A IT MI20032054A IT MI20032054 A1 ITMI20032054 A1 IT MI20032054A1
Authority
IT
Italy
Prior art keywords
active ingredient
inhaled
preparation
particles
pharmaceutical suspensions
Prior art date
Application number
IT002054A
Other languages
English (en)
Inventor
Giancarlo Ceschel
Celestino Ronchi
Original Assignee
Monteres S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monteres S R L filed Critical Monteres S R L
Priority to IT002054A priority Critical patent/ITMI20032054A1/it
Priority to US10/971,231 priority patent/US20050089476A1/en
Priority to AT04105242T priority patent/ATE475410T1/de
Priority to DE602004028328T priority patent/DE602004028328D1/de
Priority to ES04105242T priority patent/ES2349774T3/es
Priority to EP04105242A priority patent/EP1530966B1/en
Publication of ITMI20032054A1 publication Critical patent/ITMI20032054A1/it
Priority to US13/332,756 priority patent/US9155700B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/022—Filtration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
IT002054A 2003-10-22 2003-10-22 Processo per la preparazione di sospensioni farmaceutiche da inalare. ITMI20032054A1 (it)

Priority Applications (7)

Application Number Priority Date Filing Date Title
IT002054A ITMI20032054A1 (it) 2003-10-22 2003-10-22 Processo per la preparazione di sospensioni farmaceutiche da inalare.
US10/971,231 US20050089476A1 (en) 2003-10-22 2004-10-22 Process for the preparation of pharmaceutical suspensions for inhalation
AT04105242T ATE475410T1 (de) 2003-10-22 2004-10-22 Verfahren zur vorbereitung von pharmazeutischen suspensionen zur inhalativen verabreichung
DE602004028328T DE602004028328D1 (de) 2003-10-22 2004-10-22 Verfahren zur Vorbereitung von pharmazeutischen Suspensionen zur inhalativen Verabreichung
ES04105242T ES2349774T3 (es) 2003-10-22 2004-10-22 Proceso para la preparación de suspensiones farmacéuticos para inhalación.
EP04105242A EP1530966B1 (en) 2003-10-22 2004-10-22 Process for the preparation of pharmaceutical suspensions for inhalation
US13/332,756 US9155700B2 (en) 2003-10-22 2011-12-21 Process for the preparation of pharmaceutical suspensions for inhalation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT002054A ITMI20032054A1 (it) 2003-10-22 2003-10-22 Processo per la preparazione di sospensioni farmaceutiche da inalare.

Publications (1)

Publication Number Publication Date
ITMI20032054A1 true ITMI20032054A1 (it) 2005-04-23

Family

ID=34430746

Family Applications (1)

Application Number Title Priority Date Filing Date
IT002054A ITMI20032054A1 (it) 2003-10-22 2003-10-22 Processo per la preparazione di sospensioni farmaceutiche da inalare.

Country Status (6)

Country Link
US (2) US20050089476A1 (it)
EP (1) EP1530966B1 (it)
AT (1) ATE475410T1 (it)
DE (1) DE602004028328D1 (it)
ES (1) ES2349774T3 (it)
IT (1) ITMI20032054A1 (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9704186D0 (sv) * 1997-11-14 1997-11-14 Astra Ab New composition of matter
GB0806873D0 (en) * 2008-04-16 2008-05-21 Breath Ltd Steroid nebuliser formulation

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1472793A (en) * 1974-03-28 1977-05-04 Ici Ltd Pharmaceutical compositions
US4391803A (en) * 1982-04-05 1983-07-05 Hepar Industries Adrenosteriod composition and method for the treatment of shock by infusional therapy
DE3341001A1 (de) 1983-11-12 1985-05-23 Krause, Hans Jürgen Nanopartikel aus bioabbaubarem, synthetischem material, verfahren zu deren herstellung und ihre anwendung
US5002940A (en) 1984-11-06 1991-03-26 Ciba-Geigy Corporation Solid drug formulations and stable suspensions
WO1990006775A1 (en) 1988-12-14 1990-06-28 Liposome Technology, Inc. A novel nonphospholipid liposome composition for sustained release of drugs
US5246707A (en) * 1990-04-26 1993-09-21 Haynes Duncan H Sustained release delivery of water-soluble bio-molecules and drugs using phospholipid-coated microcrystals, microdroplets and high-concentration liposomes
US5091187A (en) * 1990-04-26 1992-02-25 Haynes Duncan H Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
US5803966A (en) * 1995-11-01 1998-09-08 Alcon Laboratories, Inc. Process for sizing prednisolone acetate using a supercritical fluid anti-solvent
US5874029A (en) * 1996-10-09 1999-02-23 The University Of Kansas Methods for particle micronization and nanonization by recrystallization from organic solutions sprayed into a compressed antisolvent
US5833891A (en) * 1996-10-09 1998-11-10 The University Of Kansas Methods for a particle precipitation and coating using near-critical and supercritical antisolvents
EP1033991B1 (en) * 1997-10-09 2002-04-17 Schering Corporation Mometasone furoate suspensions for nebulization
US6066292A (en) 1997-12-19 2000-05-23 Bayer Corporation Sterilization process for pharmaceutical suspensions
HK1039458B (zh) 1998-05-29 2006-09-01 Skyepharma Canada Inc. 熱保護微粒組合物及其最終蒸汽滅菌的方法
US6149864A (en) * 1998-06-25 2000-11-21 Massachusetts Institute Of Technology Supercritical fluid sterilization method
US6241969B1 (en) * 1998-06-26 2001-06-05 Elan Corporation Plc Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
IT1303692B1 (it) * 1998-11-03 2001-02-23 Chiesi Farma Spa Procedimento per la preparazione di sospensioni di particelle difarmaci da somministrare per inalazione.
GB9828721D0 (en) * 1998-12-24 1999-02-17 Glaxo Group Ltd Novel apparatus and process
JP2004525854A (ja) 1999-06-02 2004-08-26 ヘキサル・アクチェンゲゼルシャフト 水中に不溶性及び／又は難溶性である活性物質の鼻腔内投与用薬剤組成物
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
GB9918559D0 (en) * 1999-08-07 1999-10-06 Glaxo Wellcome Kk Novel pharmaceutical formulation
GB0016040D0 (en) * 2000-06-29 2000-08-23 Glaxo Group Ltd Novel process for preparing crystalline particles
IT1319665B1 (it) 2000-11-17 2003-10-23 Pharma Biotech Ltd Addotti di corticosteroidi con polimeri polisaccaridici naturali.
US6869617B2 (en) * 2000-12-22 2005-03-22 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
US6951656B2 (en) * 2000-12-22 2005-10-04 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
US6884436B2 (en) * 2000-12-22 2005-04-26 Baxter International Inc. Method for preparing submicron particle suspensions
US6977085B2 (en) * 2000-12-22 2005-12-20 Baxter International Inc. Method for preparing submicron suspensions with polymorph control
US20060003012A9 (en) * 2001-09-26 2006-01-05 Sean Brynjelsen Preparation of submicron solid particle suspensions by sonication of multiphase systems
AU2003246829A1 (en) 2002-02-19 2003-09-09 Resolution Chemicals Limited Solvent-based sterilisation of pharmaceuticals
ITMI20022674A1 (it) * 2002-12-18 2004-06-19 Chiesi Farma Spa Procedimento per la preparazione di formulazioni sterili a base di principi attivi farmaceutici cristallini micronizzati da somministrare come sospensioni acquose per inalazione.
US20040223918A1 (en) * 2003-05-07 2004-11-11 Chrysalis Technologies Incorporated Aerosolization of cromolyn sodium using a capillary aerosol generator
SE0302029D0 (sv) * 2003-07-07 2003-07-07 Astrazeneca Ab Novel process

Also Published As

Publication number Publication date
US9155700B2 (en) 2015-10-13
US20050089476A1 (en) 2005-04-28
ATE475410T1 (de) 2010-08-15
DE602004028328D1 (de) 2010-09-09
ES2349774T3 (es) 2011-01-11
US20120087957A1 (en) 2012-04-12
EP1530966B1 (en) 2010-07-28
EP1530966A1 (en) 2005-05-18

Similar Documents

Publication Publication Date Title
MXPA05012821A (es) Formulacion farmaceutica que comprende un agente activo insoluble en agua.
ATE411004T1 (de) Wirkstofffreigabesystem für photosensibilisatoren
DE69434445T2 (de) Verfahren zur sterilisation biologischer zusammensetzungen und das dabei erhaltene produkt
HK1219883A1 (zh) 磺烷基醚环糊精组合物
CA2371836A1 (en) Porous drug matrices and methods of manufacture thereof
CN1223347C (zh) 注射用西洛他唑水性制剂
GR900100481A (el) Μέ?οδος παρακευής υδατικού αιωρήματος για ουσιαστικά αδιάλυτους στο νερό ενεργούς παράγοντες.
WO2002101412A3 (en) Spray freeze-dried compositions
GEP20053602B (en) Aripiprazole for Oral Administration
EP3372226A1 (en) Targeted hydrophobic anti-tumour drug nanoformulation and preparation method thereof
DE50205571D1 (de) Verfahren zur Herstellung von direkt tablettierbaren Beta-Mannit
ES2139071T3 (es) Agente insecticida y acaricida derivado del triazol y proceso para la produccion del mismo.
ATE386725T1 (de) Heterocyclylverbindungen
CN109833329A (zh) 一种透明质酸-多孔纳米硒复合物及其制备方法与应用
ATE129898T1 (de) Cyclosporin enthaltende orale pharmazeutische zusammensetzung sowie verfahren zu deren herstellung.
CN104906044A (zh) 一种癸氧喹酯纳米制剂及其制备方法与应用
ITMI20032054A1 (it) Processo per la preparazione di sospensioni farmaceutiche da inalare.
RU2007149249A (ru) Глазные капли, содержащие рофлумиласт
ATE488226T1 (de) Mahonia aquifolium extrakt, extraktionsverfahren und diesen enthaltende pharmazeutische zusammensetzung
EP1230935A3 (de) Modifizierte Kolloide und deren Verwendung
CN106265115A (zh) 水溶性富勒烯衍生物在促进毛发生长中的应用
ATE378090T1 (de) Pharmazeutische zubereitung enthaltend wirkstoffe aus den pflanzen centella asiatica, mahonia aquifolium und viola tricolor
ATE493127T1 (de) Verwendung von levo-ornidazol zur herstellung eines antiparasitären infektionswirkstoffs
WO2000001397A1 (de) Wasserlöslicher nativer pflanzlicher trockenextrakt, insbesondere ginkgo biloba extrakt mit hohem gehalt an terpenoiden und flavonglykosiden
EP1284287A4 (en) METHOD FOR PRODUCING A VIRUS VECTOR